Syros Pharmaceuticals, Inc.

The current price of SYRS is 5.11 USD — it has decreased by 8.09% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Syros Pharmaceuticals, Inc. stocks are traded under the ticker SYRS.

Syros Pharmaceuticals, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Syros Pharmaceuticals, Inc. has a max estimate of 37.00 USD and a min estimate of 12.00 USD.

SYRS earnings for the last quarter are −1.43 USD whereas the estimation was −1.14 USD which accounts for −25.44% surprise. Estimated earnings for the next quarter are −1.14 USD. See more details about Syros Pharmaceuticals, Inc. earnings.

Yes, you can track Syros Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, SYRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Syros Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

SYRS reached its all-time high on Aug 7, 2017 with the price of 243.75 USD, and its all-time low was 2.09 USD and was reached on Oct 19, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 68.00 employees. See our rating of the largest employees — is Syros Pharmaceuticals, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Syros Pharmaceuticals, Inc. EBITDA is ‪−124.25 M‬ USD, and current EBITDA margin is ‪−1.25 K‬%. See more stats in Syros Pharmaceuticals, Inc. financial statements.